Doctors Don’Â’t Agree on Bextra Risk
The evidence behind the risk of Bextra isn’t nearly as conclusive as Vioxx, so far. This story details the preliminary nature of the data.
ADVERTISEMENT
More in Uncategorized
Past Week
-
Evidence-based medicine vs. clinical judgment: a medical student’s perspective
-
The controversy over Maintenance of Certification for grandfathered physicians
-
How hindsight bias distorts clinical medicine
-
When side effects are actually a cry for help with medication costs
-
Proactive monitoring can prevent emergencies by catching heart signals early [PODCAST]
-
Why clinician education must prioritize nutrition training
-
Past 6 Months
-
The dangers of vertical integration in health care
-
Why does sex work seem like a more viable path than medicine in 2026?
-
The 9 laws of health care quality: Why metrics miss the point
-
Politics and fear have replaced science in U.S. pain management [PODCAST]
-
From Singapore to Canada: a blueprint for primary care transformation
-
How board certification fuels the physician shortage crisis
-
Recent Posts
-
Proactive monitoring can prevent emergencies by catching heart signals early [PODCAST]
-
Health care affordability crisis: lessons from the NYC nursing strike
-
How wearable technology is changing the role of physicians
-
Workplace violence against nurses: a crisis of systemic failure
-
Ignored DNR hospital policy: a family’s tragic end-of-life story
-
Why measuring muscle mass matters more than tracking your weight [PODCAST]
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
